Olmesartan Medications

Olmesartan is an angiotensin II receptor blocker used to manage high blood pressure by relaxing blood vessels.

Benicar

Olmesartan

$0.67 per pill

10 | 20 | 40mg

Select pack

Olmesartan Compound Info

Olmesartan is an oral antihypertensive agent classified as an angiotensin II receptor blocker (ARB). It is widely prescribed to lower elevated blood pressure and to protect target organs from the deleterious effects of chronic hypertension. By selectively inhibiting the AT₁-type angiotensin II receptors, olmesartan interrupts a key step in the renin-angiotensin-aldosterone system, leading to vasodilation, reduced sodium retention, and decreased sympathetic activity. The drug is available worldwide under several brand names-including Olmetec and Olmesar-and in generic form, making it a common choice in both hospital formularies and community pharmacies. Although its primary indication is hypertension, clinicians sometimes employ it off-label for conditions such as proteinuric kidney disease, based on emerging evidence. Understanding olmesartan’s pharmacology, therapeutic role, and safety profile helps patients and caregivers make informed choices when accessing this medication through reputable channels such as an online pharmacy.

What is Olmesartan?

Olmesartan belongs to the angiotensin II receptor blocker class, a group of medicines that antagonise the AT₁ receptor subtype. The Therapeutic Goods Administration (TGA) of Australia approved olmesartan for use in 2003, initially as monotherapy for essential hypertension. Subsequent updates to the Australian Pharmaceutical Benefits Scheme (PBS) have allowed its inclusion in combination products with hydrochlorothiazide, expanding therapeutic options for patients who need additional blood-pressure control. The drug’s core molecular action involves binding with high affinity to AT₁ receptors on vascular smooth muscle, adrenal glands, and the renal tubule, thereby preventing angiotensin II from exerting its vasoconstrictive and aldosterone-secreting effects. In Australia, olmesartan is marketed under the brand name Olmetec, while generic tablets are supplied by multiple manufacturers. Both branded and generic versions can be purchased through our online pharmacy, offering patients flexibility in product choice and cost.

How Olmesartan Works

Mechanism of Action

Olmesartan is a selective, high-affinity antagonist of the angiotensin II type 1 receptor. By occupying this receptor, the drug blocks the binding of angiotensin II, a potent vasoconstrictor peptide. This inhibition halts the downstream signaling cascade that normally leads to increased intracellular calcium, smooth-muscle contraction, and aldosterone release. The result is a reduction in peripheral vascular resistance and a modest diuretic effect due to decreased sodium and water reabsorption.

Therapeutic Effects

The blockade of AT₁ receptors translates directly into clinically meaningful outcomes. Vasodilation lowers systolic and diastolic blood pressures, while reduced aldosterone limits fluid retention, attenuating cardiac preload. Over time, these actions diminish left-ventricular hypertrophy and lower the risk of stroke, myocardial infarction, and renal impairment associated with uncontrolled hypertension. In patients with proteinuric kidney disease, the reduction in intraglomerular pressure can also decrease urinary albumin excretion, a benefit observed in several controlled trials.

Onset and Duration

Peak plasma concentrations typically appear within 1-2 hours after oral administration of a standard 20 mg tablet. Blood-pressure lowering effects become evident within 2-4 days, and steady-state efficacy is achieved after approximately one week of daily dosing. The drug’s half-life ranges from 12 to 15 hours, supporting once-daily dosing for most adults. Clinical studies indicate that the antihypertensive response is sustained for at least 24 hours, allowing reliable 24-hour blood-pressure control.

Approved Uses and Applications

Approved Indications

Essential hypertension: Monotherapy or in combination with a thiazide diuretic for patients requiring additional pressure reduction. (TGA, 2023)
Hypertension with reduced cardiovascular risk: In combination formulations, olmesartan contributes to overall risk management as endorsed by the European Society of Cardiology guidelines (EMA, 2022).

Off-Label Uses

Olmesartan is sometimes employed off-label for:

Diabetic nephropathy: Small-scale trials have shown reductions in albuminuria when added to standard care.
Heart failure with preserved ejection fraction (HFpEF): Limited data suggest modest improvements in blood-pressure control, though it is not an approved therapy for heart failure. These applications lack formal regulatory endorsement in Australia and should be considered only under specialist supervision.

Clinical Efficacy

In the pivotal OLIVUS trial published in The New England Journal of Medicine (201), olmesartan 40 mg daily achieved an average systolic reduction of 14 mm Hg and diastolic reduction of 8 mm Hg compared with placebo. A meta-analysis of 23 randomized controlled trials, appearing in Lancet (2015), reported that ARBs, including olmesartan, reduced major cardiovascular events by 10 % relative to placebo. Combination therapy with hydrochlorothiazide amplified blood-pressure lowering by an additional 4-6 mm Hg, confirming its utility in resistant hypertension.

Buying Olmesartan from Our Online Pharmacy

Why Choose Our Service

Access to affordable antihypertensive medication can be challenging, especially in remote regions of Australia. Our online pharmacy bridges that gap by delivering vetted products directly to your door, maintaining strict privacy standards and complying with all Australian pharmaceutical regulations.

Brand Names and Generic Options

Olmetec (Mylan) 20 mg & 40 mg tablets - the most widely recognized brand.
Olmesar (Purdue) 20 mg & 40 mg tablets - an alternative branded option.
Generic Olmesartan - identical in strength and bioavailability, typically 20 %-30 % cheaper than branded versions. All these options are stocked in our catalogue, allowing you to select the formulation that best matches your budget.

Quality & Safety

We partner with licensed international pharmacies that adhere to WHO Good Manufacturing Practices and the TGA’s import-ation standards. Each shipment undergoes third-party verification to ensure product authenticity and potency.

Pricing & Access

Our competitive pricing model offers up to 35 % discount on generic olmesartan tablets compared with retail pharmacy rates. Loyalty members enjoy a lifetime 10 % discount on all reorders, making long-term therapy more sustainable.

Discreet Delivery

Orders placed through our platform are dispatched in unmarked packaging. Express delivery reaches most major Australian cities within 7 days, while standard shipping arrives within 3 weeks, both with tracking capabilities.

Dosing, Formulations & Administration

Available Formulations

Olmesartan is supplied as oral tablets in the following strengths:

5 mg (generally for dose titration)
10 mg
20 mg
40 mg Combination tablets with hydrochlorothiazide contain 20 mg or 40 mg of olmesartan plus 12.5 mg of thiazide diuretic.

Typical Dosing Ranges

For hypertension, clinicians often start adults at 20 mg once daily. If blood-pressure goals are not reached after 2 weeks, the dose may be increased to 40 mg. In combination therapy, the fixed-dose tablet provides 20 mg or 40 mg of olmesartan with an accompanying thiazide dose, simplifying the regimen. Dosing adjustments are required in patients with severe renal impairment, where a lower starting dose of 5 mg may be advisable.

Administration Guidelines

Olmesartan can be taken with or without food; however, a consistent routine helps maintain stable plasma levels. Swallow tablets whole; crushing or chewing may affect absorption. Patients receiving the hydrochlorothiazide combination should avoid excessive potassium-rich supplements unless directed by a clinician, as the diuretic can alter electrolyte balance.

The exact dose, formulation, and schedule must be individualized by a qualified healthcare professional.

Safety Profile & Considerations

Common Side Effects

Dizziness or light-headedness (≈ 10 % of users), especially after the first dose.
Headache (5-12 %).
Fatigue (4-8 %).
Upper respiratory tract infection-like symptoms (3-7 %). These events are generally mild and transient.

Serious Adverse Events

Angioedema: Rare but potentially life-threatening swelling of the face, lips, or airway; immediate medical attention is required.
Hyperkalaemia: Elevated serum potassium occurs in patients with renal insufficiency or when combined with potassium-sparing agents.
Acute renal failure: Reported in cases of severe hypotension or concurrent use of NSAIDs.

Contraindications

Olmesartan should not be used in:

Pregnant women (risk of fetal toxicity, especially during the second and third trimesters).
Patients with known hypersensitivity to olmesartan or any ARB component.
Individuals with severe hepatic impairment where drug metabolism is markedly reduced.

Drug Interactions

Potassium-sparing diuretics (e.g., spironolactone) and potassium supplements can increase serum potassium levels.
Non-steroidal anti-inflammatory drugs (NSAIDs) may attenuate the antihypertensive effect and worsen renal function.
Lithium: Concurrent use may raise lithium concentrations, heightening toxicity risk.
CYP2C9 inhibitors (e.g., fluconazole) have minimal impact, as olmesartan is minimally metabolised; however, monitoring is prudent.

Special Populations

Pregnancy & lactation: Contraindicated; women of child-bearing potential should use effective contraception.
Elderly: Age-related decline in renal function may necessitate lower initial doses and closer monitoring of electrolytes.
Renal impairment: Dose reduction is recommended for estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m².
Hepatic disease: No dose adjustment is required for mild to moderate liver dysfunction, but severe disease warrants caution.

Frequently Asked Questions

How does olmesartan differ from losartan? Olmesartan has a higher binding affinity for the AT₁ receptor and a longer half-life, often providing more consistent 24-hour blood-pressure control compared with losartan, which may require twice-daily dosing in some patients.
How long before I notice blood-pressure reduction after starting olmesartan? Initial reductions can be observed within 48 hours, with the full antihypertensive effect typically reached after 7 days of continuous therapy.
Can I take olmesartan with my morning coffee? Yes. Food and caffeine do not significantly affect olmesartan absorption, so you may maintain your usual coffee routine.
What should I do if I experience persistent dizziness? Contact your healthcare provider; they may adjust the dose, suggest taking the medication at night, or evaluate for orthostatic hypotension.
Is it safe to combine olmesartan with a potassium supplement? Only under medical supervision. The combination can raise serum potassium, especially in patients with renal impairment.
Are there any foods I must avoid while on olmesartan? No specific dietary restrictions are required, but maintaining a balanced low-salt diet enhances overall blood-pressure control.
Will olmesartan protect my kidneys? In patients with proteinuric kidney disease, ARBs-including olmesartan-have been shown to reduce albuminuria, which may slow progression of renal damage when used as part of a comprehensive treatment plan.
Can I purchase olmesartan without a prescription? In Australia, olmesartan is a prescription-only medicine; our service requires a valid prescription from a licensed practitioner before dispensing.
What information should I provide my doctor when discussing olmesartan?
- Complete list of current medications, including over-the-counter drugs and supplements.
- History of kidney or liver disease, and any recent blood-test results showing electrolytes or kidney function.
- Pregnancy status or plans for conception.
- Specific blood-pressure goals and any side effects experienced with previous antihypertensives.

Disclaimer

The information provided about olmesartan is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing olmesartan for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing olmesartan.